JLE

Médecine thérapeutique

MENU

Ocular rosacea and complications about 10 cases Volume 24, issue 2, Mars-Avril 2018

  • [1] Berg B., Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69:419-423.
  • [2] Erzurum S.A., Feder R.S., Greenwald M.J. Acne rosacea with keratitis in childhood. Arch Ophthalmol. 1993;111:228-230.
  • [3] Browning D.J., Proia A.D. Ocular rosacea. Surv Ophthalmol. 1986;31:145-158.
  • [4] Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65:458-463.
  • [5] Starr P.A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969;62:9-11.
  • [6] Hoang-Xuan T. Rosacée oculaire. J Fr Ophtalmol. 1999;22: 467-474.
  • [7] Culbertson W.W., Huang A.J.W., Mandelbaum S.H., Pflugfelder S.C., Boozalis G.T., Miller D. Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology. 1993;100:1358-1366.
  • [8] Zaidman G.W., Brown S.I. Orally administered tetracycline for phlyctenular keratoconjunctivitis. Am J Ophthalmol. 1981;92:173-182.
  • [9] Akpek E.K., Merchant A., Pinar V., Foster C.S. Ocular rosacea. Ophthalmology. 1997;104:1863-1867.
  • [10] Barnhorst D.A. Jr., Foster J.A., Chern K.C., Meisler D.M. The efficacy of topical metronidazole in the treatment of ocular rosacea. Ophthalmology. 1996;103:1880-1883.
  • [11] Bartholomew R.S., Reid B.J., Cheesbrough M.J., McDonald M., Galloway N.R. Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol. 1982;66:386-388.
  • [12] Frucht-Pery J., Sagi E., Hemo I., Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol. 1993;116:88-92.
  • [13] Frucht-Pery J., Chayet A.S., Feldman S.T., Lin S., Brown S.I. The effect of doxycycline on ocular rosacea. Am J Ophthalmol. 1989;107:434-435.
  • [14] Salamon S.M. Tetracyclines in ophthalmology. Surv Ophthalmol. 1985;29:265-275.
  • [15] Knight A.G., Vickers C.F. A follow-up of tetracycline-treated rosacea. Br J Dermatol. 1975;93:577-580.
  • [16] Doan S. Les nouveaux traitements pour les pathologies de la surface oculaire. Quelle place pour les immunosuppresseurs locaux dans les pathologies de la surface oculaire ? Reflex Ophtalmol 2010 ; 15 : 10-3.
  • [17] Seal D.V., Wright P., Ficker L. Placebo-controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea. Br J Ophthalmol. 1995;79:42-45.